News summary

PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study

Source: PR Newswire • Published: 12 Sept 2026, 01:26

Summarized by Masters of Longevity from PR Newswire.

Announcement that a vision diagnostics startup received NEI Phase I SBIR funding to develop a faster, tablet-based recovery test for macular health assessment.

PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study
Key Takeaways
  • PerZeption received a Phase I SBIR grant from the National Eye Institute to fund an AMD recovery-function study.
  • The project will adapt PerZeption's AIM platform to measure full achromatic and chromatic photostress recovery functions.
  • The Phase I study will generate clinical feasibility data to support regulatory pathway and routine clinical use.
Read the full article at PR Newswire

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.